NCT00001333View on ClinicalTrials.gov

Phase I Study of Intrathecal Topotecan

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

February 28, 1993

Study Completion Date

December 31, 2000

Conditions

LeukemiaLymphomaMeningeal Neoplasms

Interventions

DRUG

topotecan

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00001333 - Phase I Study of Intrathecal Topotecan | Biotech Hunter | Biotech Hunter